The Immunomodulating Role of B-cells in IgA Nephropathy – Focus on APRIL
This session will provide a comprehensive overview of the immunomodulating role of B cells in IgAN, from basic biology to clinical implications.
User experience form
Attend live and virtual events that provide a platform for education and collaborative discussion about the management of kidney disease and strategies to improve kidney health.
Any NephU member can request a presentation for their region or organization at no charge.
This session will provide a comprehensive overview of the immunomodulating role of B cells in IgAN, from basic biology to clinical implications.
This presentation is an overview of IgA Nephropathy (IgAN), the most common primary glomerular nephropathy worldwide.
This presentation is an overview of IgA Nephropathy (IgAN), the most common primary glomerular nephropathy worldwide.
This presentation is an overview of IgA Nephropathy (IgAN), the most common primary glomerular nephropathy worldwide.
Step into an educational journey designed to deepen your understanding of IgA Nephropathy (IgAN) through an engaging, multi-format learning experience—powered by cutting-edge tools and real-world insights.
This presentation is an overview of IgA Nephropathy (IgAN), the most common primary glomerular nephropathy worldwide.
Learn about health literacy and how it impacts patients with CKD including IgAN. Dr. Velez will share her expertise as a nephrologist treating patients with IgAN as well as discuss some of the challenges in her own practice.
This presentation is an overview of IgA Nephropathy (IgAN), the most common primary glomerular nephropathy worldwide.
This presentation is an overview of IgA Nephropathy (IgAN), the most common primary glomerular nephropathy worldwide.
his webinar will focus on the current biomarker landscape as well as novel biomarkers that are currently being studied. The webinar will also focus on why biomarkers are needed and what the unmet need is.
Notifications